According to the Legislative Budget Board (LBB), HB 475 would have a negative fiscal impact of approximately $4.1 million in General Revenue-related funds during the 2026–27 biennium. The bill would require the Health and Human Services Commission (HHSC) to create a new Medicaid benefit for multisystemic therapy (MST) services and establish a separate provider type for reimbursement. Although the bill takes effect September 1, 2025, HHSC estimates that implementation would take 12 to 18 months because of required policy revisions, rate setting, and system updates, with services beginning September 1, 2026.
The primary fiscal driver is the cost of providing the new Medicaid benefit. HHSC estimates an average monthly caseload of approximately 1,094 recipients in fiscal year 2027, growing to more than 2,100 recipients by fiscal year 2030, at an estimated annual cost of $10,821 per recipient. While some of these costs would be offset by reduced utilization of other mental health services and modest increases in insurance premium tax revenue, the net effect remains a continuing increase in state Medicaid expenditures. General Revenue costs are projected to rise from $3.8 million in fiscal year 2027 to approximately $7.1 million annually by fiscal year 2030, indicating that the fiscal impact is ongoing rather than one-time.
The bill also requires upfront administrative and technology investments. HHSC estimates one-time technology and implementation costs of $1.6 million (All Funds) in fiscal year 2026, including system modifications and establishment of the new provider type, followed by approximately $115,500 annually for ongoing system maintenance and updates.
The LBB further concludes that the legislation would not have a significant fiscal impact on local governments. The anticipated costs are borne primarily by the state Medicaid program, with federal Medicaid matching funds covering a substantial share of total expenditures while General Revenue finances the state's matching obligation.
HB 475 seeks to expand access to evidence-based behavioral health treatment by requiring the Health and Human Services Commission (HHSC) to provide Medicaid reimbursement for multisystemic therapy (MST) services and establish a dedicated provider type for those delivering the treatment. While the bill is intended to improve outcomes for high-risk youth and reduce reliance on more costly interventions, it accomplishes those objectives by expanding the Medicaid program through a new statutory benefit mandate.
From a limited-government perspective, the bill increases the size and scope of state government by permanently expanding Medicaid coverage and requiring HHSC to administer an additional provider classification and reimbursement program. Although the legislation does not create a new agency or impose significant new regulations on private individuals or businesses, it establishes a continuing government obligation to finance a specific healthcare service. The LBB estimates the bill will increase General Revenue expenditures by approximately $4.1 million during the 2026–27 biennium, with annual costs exceeding $7 million in future years, creating an ongoing burden on taxpayers without a sunset provision or other meaningful limitation on future program growth.
The bill also establishes a precedent for legislatively mandating Medicaid reimbursement for specific therapies, which could encourage future benefit expansions through statute rather than allowing policymakers to evaluate Medicaid services as part of a comprehensive budget and policy process. While multisystemic therapy may provide meaningful clinical benefits, those potential outcomes do not outweigh the long-term implications of expanding a taxpayer-funded entitlement program. For lawmakers committed to limiting the growth of government, restraining recurring public expenditures, and preserving legislative flexibility over Medicaid policy, the recommendation is Vote No.